Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 1.17
-6.4 %
$ 53.5 M
Market Cap
-3.08
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
-0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
InterCure Ltd.
INCR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart INCR
EBIT FORECAST
EBIT Forecast Chart INCR
NET INCOME FORECAST
Net Income Chart INCR